Title : Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma.

Pub. Date : 2019

PMID : 31440466






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In addition, a combination of MK2 inhibitor IV and the key MM therapeutic agents including bortezomib, doxorubicin, or dexamethasone facilitated curative effects on inhibiting MM cell proliferation. Bortezomib MAPK activated protein kinase 2 Homo sapiens